Business
Currency:USD
2024/FY
Stock NameRevenueRatio
肿瘤╱免疫业务-上市产品271.53M43.09%
Other business266.84M42.34%
肿瘤╱免疫业务-研发91.83M14.57%
Product
Currency:USD
2024/FY
Stock NameRevenueRatio
肿瘤╱免疫业务-上市产品271.53M43.09%
Other business266.84M42.34%
肿瘤╱免疫业务-研发91.83M14.57%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
China452.41M71.79%
美国及其他国家地区177.79M28.21%